375 results
Page 5 of 19
8-K
EX-99.1
38vgzx498b87t
17 Dec 19
ImmunoGen Announces Accelerated Approval Pathway for Mirvetuximab Soravtansine in Ovarian Cancer
6:37am
8-K
EX-99.1
2daqwtli3s8bk9nic
1 Nov 19
ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial Results
6:54am
8-K
EX-99.1
pr41h3f6u0 em4
30 Sep 19
ImmunoGen Presents Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer at ESMO
8:08am
8-K/A
EX-99.1
zxayyy xj
2 Aug 19
ImmunoGen Reports Recent Progress and Second Quarter 2019 Financial Results
10:33am
8-K
EX-99.1
caojv3
2 Aug 19
ImmunoGen Reports Recent Progress and Second Quarter 2019 Financial Results
6:38am
8-K
EX-99.1
zylswp sdcj75azk7
27 Jun 19
ImmunoGen Announces Completion of Operational Review
6:35am
8-K
EX-99.1
rgmwux
3 May 19
ImmunoGen Reports Recent Progress and First Quarter 2019 Financial Results
6:36am
DEFA14A
5xsspcw
30 Apr 19
Additional proxy soliciting materials
12:23pm
8-K
EX-99.1
57i xfjibzhao
8 Feb 19
ImmunoGen Reports Recent Progress and 2018 Operating Results
6:37am
8-K
EX-99.1
jjpo1o7i
2 Nov 18
ImmunoGen Reports Recent Progress and Third Quarter 2018 Operating Results
6:36am